Project Grant R01GM164296
- Federal Grant Award Summary Yale University received a $2.1 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2029. The award supports fundamental research investigating the biological role and pharmacology of the EXPERA family of membrane proteins, specifically sigma-2 receptor (TMEM97) and transmembrane 6 superfamily member 2 (TM6SF2),...
- Federal Grant Award Summary Yale University received a $304,970 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026 through May 31, 2031. This award funds the development of next-generation mass spectrometry (MS)-based technologies designed to directly analyze membrane protein complexes and their lipid environments with precise molecular and nanoscale spatial resolution....
- Federal Grant Award Summary Yale University received a $460,740 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2030. The award funds research to develop novel quantitative experimental and computational methods for studying continuous phenotypic transitions in cellular states. The primary deliverables include the application of Proteolysis-Targeting...
- Federal Grant Award Summary Yale University received a $669,801 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025 through July 31, 2030. The award funds research into proteomic and phosphoproteomic remodeling mechanisms in aneuploid cells—cells with abnormal chromosome numbers associated with cancers and trisomic syndromes. The project leverages mass spectrometry...
- Federal Project Grant Award Summary Yale University received a $2.31 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 8, 2025, with a completion date of September 7, 2029. This four-year research initiative will investigate the molecular mechanisms governing large dense-core vesicle (LDCV) fusion with the plasma membrane, a process critical to secretion of peptides,...
- Federal Grant Award Summary Yale University received a $1,205,462 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 10, 2025 through February 28, 2030. The award supports fundamental research investigating how biopolymers—including proteins, DNA, and RNA—alter their conformations at aqueous interfaces and how hydration structures modulate this behavior. This research...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $440,000 through its Biomedical Research and Research Training program (CFDA 93.859) to the Sloan-Kettering Institute for Cancer Research, effective August 1, 2025, with completion targeted for May 31, 2030. This Project Grant supports fundamental research investigating the mechanisms of lipid droplet (LD) protein targeting—a critical area of cell biology with direct implications for...
- Federal Grant Award Summary Yale University received a $361,283 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), with an award date of September 8, 2025, and a completion date of July 31, 2030. The award supports research titled "Frontiers in Measuring and Simulating Molecular Structures and Processes," conducted at Yale's New Haven, Connecticut facility. The research focuses on...
- Grant Award Summary The University of Virginia received a $444,125 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 1, 2025, with a completion date of June 30, 2030. This research project, titled "Unraveling the Mechanisms of Protein Sorting and Localization to Organelles," aims to elucidate the molecular mechanisms governing protein biogenesis on mitochondrial and...
- Federal Project Grant Award Summary Yale University received a $2.014 million Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) effective June 1, 2026, with completion targeted for May 31, 2030. The award funds development of a synthetic biology tool designed to engineer proteins with multiple posttranslational modifications (PTMs) and elucidate their binding functions. The project leverages Genomically...
Grant Award Summary Yale University received a $605,140 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded June 1, 2026, with completion targeted for March 31, 2030. The grant supports fundamental research to elucidate cellular and molecular mechanisms of lipid-mediated protein trafficking through the mammalian Golgi complex, a critical organelle responsible for protein sorting, post-translational modification, and intracellular cargo trafficking. Understanding these mechanisms addresses a longstanding gap in cell biology, as dysregulation of Golgi structure and function is associated with cancer and neuropathology. The research deliverables encompass two primary aims: characterization of the Golgi trafficking pathway machinery at the cellular level (Aim 1) and elucidation of mechanistic function (Aim 2). The investigation focuses on palmitoylation-dependent protein sorting and the role of specific regulatory components, including TUG/ASPCR1 and associated tether and SNARE fusion machinery. The project will examine trafficking of physiologically relevant cargo such as glucose transporters and G protein-coupled receptors. Outcomes are expected to provide foundational insights into mammalian cellular biology while generating knowledge applicable to cancer and neurodegenerative disease research.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $605.1k | 5/14/26 |